# A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers

> **NCT05753878** · PHASE1 · COMPLETED · sponsor: **Huahui Health** · enrollment: 62 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** HH-120 nasal spray, PartA cohort 1
- **DRUG:** HH-120 nasal spray, Part A cohort 2-7
- **DRUG:** HH-120 nasal spray, Part A cohort 8-9
- **DRUG:** HH-120 nasal spray, Part B
- **OTHER:** Placebo nasal spray, Part B

## Key facts

- **NCT ID:** NCT05753878
- **Lead sponsor:** Huahui Health
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-08
- **Primary completion:** 2023-01-09
- **Final completion:** 2023-01-09
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05753878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05753878, "A Study to Evaluate the Safety and Pharmacokinetics of HH-120 Nasal Spray in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05753878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*